Purple Book reference family · 351(a) biologic
fremanezumab-vfrm (Ajovy)
fremanezumab-vfrm is an FDA-licensed reference biologic from Teva Branded Pharmaceutical Products R&D, Inc..
351(a) biologicBLA 761089 Teva Branded Pharmaceutical Products R&D, Inc.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2018
Reference product
Originator biologic
351(a)BLA 761089
Ajovy fremanezumab-vfrm
Teva Branded Pharmaceutical Products R&D, Inc.
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference fremanezumab-vfrm product.
8 yr ago
fremanezumab-vfrm: frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for fremanezumab-vfrm.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
